Invesco
COGT icon

Invesco’s Cogent Biosciences COGT Stock Holding History

Invesco’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$101M Buy
2,609,141
+179,512
+7% +$6.28M 0.01% 891
2026
Q1 		$93.5M Buy
2,429,629
+1,843,864
+315% +$68.1M 0.01% 856
2025
Q4 		$20.8M Buy
585,765
+213,495
+57% +$6M ﹤0.01% 1447
2025
Q3 		$5.35M Buy
372,270
+259,210
+229% +$3.07M ﹤0.01% 2199
2025
Q2 		$812K Buy
113,060
+44,317
+64% +$246K ﹤0.01% 2938
2025
Q1 		$412K Buy
68,743
+30,102
+78% +$236K ﹤0.01% 3230
2024
Q4 		$301K Sell
38,641
-455,437
-92% -$4.54M ﹤0.01% 3414
2024
Q3 		$5.34M Buy
494,078
+330,112
+201% +$3.21M ﹤0.01% 2183
2024
Q2 		$1.38M Buy
163,966
+127,124
+345% +$964K ﹤0.01% 2780
2024
Q1 		$248K Buy
36,842
+2,102
+6% +$13K ﹤0.01% 3580
2023
Q4 		$204K Buy
34,740
+2,066
+6% +$15.8K ﹤0.01% 3564
2023
Q3 		$319K Buy
32,674
+1,363
+4% +$16.2K ﹤0.01% 3430
2023
Q2 		$371K Buy
31,311
+3,697
+13% +$42.4K ﹤0.01% 3405
2023
Q1 		$298K Buy
27,614
+9,999
+57% +$128K ﹤0.01% 3504
2022
Q4 		$204K Sell
17,615
-439,868
-96% -$5.45M ﹤0.01% 3680
2022
Q3 		$6.83M Sell
457,483
-436,109
-49% -$5.98M ﹤0.01% 2033
2022
Q2 		$8.06M Buy
893,592
+881,334
+7,190% +$6.02M ﹤0.01% 1988
2022
Q1 		$92K Buy
12,258
+459
+4% +$3.2K ﹤0.01% 3873
2021
Q4 		$102K Sell
11,799
-336
-3% -$2.92K ﹤0.01% 3900
2021
Q3 		$102K Sell
12,135
-717,711
-98% -$5.5M ﹤0.01% 3939
2021
Q2 		$5.92M Buy
729,846
+26,762
+4% +$226K ﹤0.01% 2360
2021
Q1 		$6.17M Buy
703,084
+3,084
+0.4% +$29.7K ﹤0.01% 2266
2020
Q4 		$7.86M Buy
+700,000
New +$7.69M ﹤0.01% 1933

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco's COGT Position: Q2 2026 in Review

Invesco increased its Cogent Biosciences (COGT) stake by 7.4% in Q2 2026, buying an estimated $6.28M and bringing the position to 2,609,141 shares worth $101M. The position accounts for 0.01% of the portfolio, ranked #891.

Invesco first reported a position in COGT in Q4 2020 and has held it in 23 quarters since. 324 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Invesco held 2,609,141 shares of Cogent Biosciences worth $101M as of Q2 2026.
  • Invesco bought 179,512 Cogent Biosciences shares in Q2 2026, an estimated $6.28M.
  • Cogent Biosciences made up 0.01% of Invesco's portfolio in Q2 2026, its #891 holding.
  • Invesco first reported a position in Cogent Biosciences in Q4 2020 and has held it in 23 quarters since.
  • 324 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.